Asthma Control Test
Also known as: ACT, Asthma Control Test, Asthma Control Assessment
The ACT is a simple, rapid, patient-centered measure of asthma control. Developed by Robert Nathan and colleagues in 2004, this 5-item questionnaire quantifies how asthma symptoms, activity limitation, and nighttime awakening affect daily life. It is the most widely used asthma control measure in clinical practice and is recommended by major asthma guidelines as a standard assessment tool.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
The ACT is indicated for assessing asthma control in all asthma patients. Use cases include baseline assessment to quantify control and guide initial treatment, monitoring at each clinical visit (quarterly or more frequently for uncontrolled asthma) to track response and inform therapy adjustments, identifying patients at risk for exacerbation (low ACT predicts future exacerbations), outcome assessment in clinical trials as a primary or co-primary endpoint, and quality improvement in asthma care. The ACT is valuable in both primary care (screening for inadequate control) and specialty asthma clinics (monitoring treatment efficacy). A pediatric ACT (cACT, 7 items) exists for children 4-11 years; the standard ACT applies to ages 12 and older.
Strengths & limitations
- Exceptional brevity—5 items, 1-2 minute completion, fits seamlessly into any clinic workflow, increasing likelihood of routine use
- Strong psychometric properties—extensively validated in diverse asthma populations with demonstrated internal consistency (Cronbach's α 0.80-0.90), test-retest reliability (ICC 0.80-0.95), and responsiveness to treatment
- Clinically meaningful cutoff—ACT ≥20 clearly indicates controlled asthma; <20 signals need for action, guiding treatment escalation decisions
- Predicts exacerbation risk—low baseline ACT predicts asthma exacerbations within 3-6 months, enabling early intervention in high-risk patients
- Free and universally accessible—no licensing restrictions; available in multiple languages via asthma societies (Global Initiative for Asthma, American Academy of Allergy Asthma & Immunology)
- Pediatric and adult versions—cACT (ages 4-11) and standard ACT (ages 12+) enable longitudinal assessment across the lifespan
- Symptom-based only—does not measure objective lung function (FEV1), airway hyperresponsiveness, or inflammation; spirometry and allergy/inflammation markers must be assessed separately
- Does not diagnose asthma—measures control in presumed asthma; cannot establish diagnosis, which requires clinical history and objective evidence (spirometry, peak flow variability, bronchial challenge test)
- Limited discriminant specificity—cannot distinguish asthma control from control of other conditions (e.g., GERD-induced cough, vocal cord dysfunction presenting as dyspnea). Clinical assessment must confirm asthma diagnosis.
- Potential response bias—patients may under-report symptoms if they minimize disease severity or fear medication escalation; conversely, may over-report if seeking validation or treatment intensification
- Does not assess exacerbation frequency directly—while low ACT predicts future exacerbations, a single ACT score does not reveal past exacerbation history; must ask separately
Frequently asked
A patient has ACT 19 (not controlled) but FEV1 85% predicted. Should I escalate therapy?
Yes, likely. ACT <20 indicates symptomatic suboptimal control, which predicts exacerbation risk and impaired quality of life, regardless of FEV1. FEV1 85% is borderline low-normal. Consider escalation: if on no inhaled corticosteroid (ICS), initiate ICS; if on low-dose ICS, increase dose or add long-acting beta-agonist (LABA); if on ICS/LABA, ensure adherence, technique, and trigger control. Reassess ACT in 4-6 weeks.
What does a change of 3 points on the ACT mean?
A 3-point change (e.g., ACT 17 to 20) is the minimally important difference and represents clinically meaningful change in asthma control. Improvement indicates treatment benefit; deterioration indicates loss of control and need for reassessment and possible therapy adjustment.
Should I use ACT or ACQ (Asthma Control Questionnaire)?
Both are valid. ACT is shorter (5 items, 1-2 min), simpler, with clear cutoff (≥20 = controlled), preferred for routine primary care. ACQ is longer (6-7 items), more detailed, captures mild symptom variation better, preferred for research and specialist management of difficult asthma. Use ACT for screening and regular monitoring; ACQ for research or detailed asthma characterization.
Is ACT appropriate in ACOS (Asthma-COPD Overlap)?
Yes. ACT measures asthma control component of ACOS. However, ACOS patients may also have significant COPD burden (dyspnea, exacerbations) not fully captured by ACT. Combine ACT with CAT (COPD Assessment Test) or mMRC dyspnea scale for comprehensive assessment of both disease components.
Sources
- Nathan, R. A., Sorkness, C. A., Kosinski, M., Schatz, M., Li, J. T., Marcus, P., ... & Pendergraft, T. B. (2004). Development of the asthma control test: A survey for assessing asthma control in children and adults. Allergy and Asthma Proceedings, 25(1), 1-6. DOI: 10.1016/j.jaci.2003.09.008 ↗
- Schatz, M., Kosinski, M., Yarlas, A. S., Pendergraft, T. B., Kowgier, M., & Lee, J. H. (2012). The minimally important difference of the Asthma Control Test. Journal of Allergy and Clinical Immunology, 126(3), 581-587.e10. link ↗
- Juniper, E. F., O'Byrne, P. M., Guyatt, G. H., Ferrie, P. J., & King, D. R. (1999). Development and validation of a questionnaire to measure asthma control. European Respiratory Journal, 14(4), 902-907. DOI: 10.1034/j.1399-3003.1999.14d29.x ↗
How to cite this page
ScholarGate. (2026, June 3). Asthma Control Test. ScholarGate. https://scholargate.app/en/health-outcomes/asthma-control-test
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- CATHealth Outcomes↔ compare
- CHQHealth Outcomes↔ compare
- EORTC QLQ-C30Health Outcomes↔ compare
- PDQ-39Health Outcomes↔ compare